CANadian CAnagliflozin REgistry (CanCARE): a prospective, observational, assessment of canagliflozin (CANA) treatment in type 2 diabetes; 12 month resultsV. Woo,A. Bell,M. Clement,F. Camacho,N. Georgijev,J. B. Rose, W. Rapattoni,H. S. BajajDIABETOLOGIA(2018)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要